How can oral paediatric formulations be improved? A challenge for the XXI century
- PMID: 32980507
- DOI: 10.1016/j.ijpharm.2020.119905
How can oral paediatric formulations be improved? A challenge for the XXI century
Abstract
Paediatric oral formulations need to be improved. This is an indisputable fact that has gain attention from the regulators, the medical staff, and researchers. The lack of adequate medicines developed for children, resulted in several off-label and unlicensed prescriptions, increasing the risks of adverse drug reactions. When formulating a paediatric medicine, it is necessary to consider the product acceptability determined by the characteristics of both product and user (Gerrard et al., 2019). In the last decades, the regulators have issued guidelines to facilitate the development of medicines specialized for children. The use of oral solid dosage forms instead of liquid dosage forms has been preferred due to advantages, e.g., increase stability and shelf-life. However, palatability and size are common difficulties in solid forms. Many aspects need to be considered when developing a new oral paediatric formulation, although, palatability is recognized as a common reason for non-compliance among children. There are many methods that can be used to improve palatability; however, innovative approaches are still needed. In this review, an overview on oral paediatric formulations with emphasis on their palatability is given. Some of the most innovative approaches are discussed, for example, the use of crystal engineering to improve drug palatability, the development of candy-like pharmaceutical forms, and the use of 3D printing to develop personalized medicines for children.
Keywords: Candy-like formulations; Crystal engineering; Drug palatability; Formulations acceptability; Oral paediatric formulations; Personalized medicine.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
The impact of drug palatability on prescribing and dispensing of antibiotic formulations for paediatric patients: a cross-sectional survey of general practitioners and pharmacists.Fam Pract. 2024 Dec 2;41(6):962-969. doi: 10.1093/fampra/cmad071. Fam Pract. 2024. PMID: 37410016 Free PMC article.
-
How to Modify Drug Release in Paediatric Dosage Forms? Novel Technologies and Modern Approaches with Regard to Children's Population.Int J Mol Sci. 2019 Jun 29;20(13):3200. doi: 10.3390/ijms20133200. Int J Mol Sci. 2019. PMID: 31261877 Free PMC article. Review.
-
Innovations in Chewable Formulations: The Novelty and Applications of 3D Printing in Drug Product Design.Pharmaceutics. 2022 Aug 18;14(8):1732. doi: 10.3390/pharmaceutics14081732. Pharmaceutics. 2022. PMID: 36015355 Free PMC article. Review.
-
Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.Adv Drug Deliv Rev. 2014 Jun;73:14-33. doi: 10.1016/j.addr.2014.02.012. Epub 2014 Mar 12. Adv Drug Deliv Rev. 2014. PMID: 24614069 Review.
-
Orodispersible drug formulations for children and elderly.Eur J Pharm Sci. 2015 Jul 30;75:2-9. doi: 10.1016/j.ejps.2015.02.015. Epub 2015 Feb 28. Eur J Pharm Sci. 2015. PMID: 25736528 Review.
Cited by
-
Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension.Pharmaceutics. 2023 Jan 29;15(2):446. doi: 10.3390/pharmaceutics15020446. Pharmaceutics. 2023. PMID: 36839767 Free PMC article.
-
Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review.Pharmaceutics. 2023 Apr 21;15(4):1306. doi: 10.3390/pharmaceutics15041306. Pharmaceutics. 2023. PMID: 37111791 Free PMC article. Review.
-
Off‑label and unapproved pediatric drug utilization: A meta‑analysis.Exp Ther Med. 2024 Aug 30;28(5):412. doi: 10.3892/etm.2024.12701. eCollection 2024 Nov. Exp Ther Med. 2024. PMID: 39268368 Free PMC article.
-
Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children.Pharmaceutics. 2025 May 17;17(5):658. doi: 10.3390/pharmaceutics17050658. Pharmaceutics. 2025. PMID: 40430948 Free PMC article.
-
Novel Soft Dosage Forms for Paediatric Applications: Can We 3D-Print Them or Not?Gels. 2025 Mar 8;11(3):187. doi: 10.3390/gels11030187. Gels. 2025. PMID: 40136892 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources